Atlas Trials

Ma Fei，MD

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ma Fei，MD

RecordFirmDate
Efficacy and Safety of Biweekly Regimen of Eribulin Versus a Standard Regimen for the Treatment of Locally Recurrent or Metastatic HER2-negative Breast Cancer: a Multicenter, Randomized, Open-label, Phase III Trial (NCT06857305)Ma Fei，MD2023-07-13
The Psychology of Chinese Breast Cancer Patients (NCT05055375)Ma Fei，MD2019-04-25

Track Ma Fei，MD automatically

Every clearance here is in the API, with alerts when new ones post.